agilon health (NYSE:AGL) Trading 5.6% Higher Following Analyst Upgrade

agilon health, inc. (NYSE:AGL) shares rose 5.6% during mid-day trading on Thursday after Royal Bank of Canada raised their price target on the stock from $3.00 to $3.50. Royal Bank of Canada currently has an outperform rating on the stock. agilon health traded as high as $3.58 and last traded at $3.55. Approximately 318,263 shares changed hands during trading, a decline of 94% from the average daily volume of 5,431,873 shares. The stock had previously closed at $3.36.

AGL has been the topic of a number of other reports. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Sanford C. Bernstein lifted their price objective on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Citigroup upgraded shares of agilon health from a “sell” rating to a “neutral” rating and boosted their price objective for the company from $1.75 to $2.25 in a research report on Friday, January 10th. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Finally, Needham & Company LLC reissued a “hold” rating on shares of agilon health in a report on Wednesday. Two research analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $3.95.

Insider Transactions at agilon health

In other news, Director John William Wulf bought 45,000 shares of the company’s stock in a transaction that occurred on Thursday, December 5th. The shares were acquired at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the completion of the acquisition, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Karen Mcloughlin bought 25,000 shares of the business’s stock in a transaction that occurred on Friday, December 13th. The shares were acquired at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the transaction, the director now owns 73,166 shares in the company, valued at $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have bought 77,500 shares of company stock worth $169,600. Insiders own 3.20% of the company’s stock.

Institutional Trading of agilon health

Several large investors have recently modified their holdings of AGL. Vanguard Group Inc. lifted its position in shares of agilon health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after acquiring an additional 272,787 shares during the period. Capital International Investors increased its position in shares of agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after acquiring an additional 9,346,295 shares in the last quarter. State Street Corp increased its holdings in agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after purchasing an additional 215,733 shares in the last quarter. Millennium Management LLC raised its position in agilon health by 187.8% in the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after buying an additional 4,706,357 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in shares of agilon health by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock valued at $13,168,000 after purchasing an additional 35,207 shares during the last quarter.

agilon health Stock Performance

The company’s 50 day simple moving average is $2.91 and its 200 day simple moving average is $3.04. The stock has a market cap of $1.49 billion, a PE ratio of -3.84 and a beta of 0.66. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.